The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex several-stage synthetic process. Initial routes focused on protein fragment coupling, utilizing solid-phase https://craiguyfb443556.dgbloggers.com/41128136/synthesis-and-research-uses-of-retatrutide